Editor
WASHINGTON: US health officials are warning against overuse of the lone drug available to treat monkeypox, saying that even a small mutation in the virus could render the pills ineffective.
The food and drug administration updated its guidance this week for Tpoxx, which has been prescribed to tens of thousands of patients afflicted with the virus.
In an online update, FDA officials cautioned that a single molecular change to monkeypox “could have a large impact on the antiviral activity of…
The food and drug administration updated its guidance this week for Tpoxx, which has been prescribed to tens of thousands of patients afflicted with the virus.
In an online update, FDA officials cautioned that a single molecular change to monkeypox “could have a large impact on the antiviral activity of…
